Navigation Links
The Price Of Autism

Michael Ganz, an assistant Professor of Society, Human Development, and Health at Harvard School of Public Health, has examined the cost of autism for US society //and has found that the disease costs a person $3.2 million over the entire life span. Ganz has published his research in the new book Understanding Autism: From Basic Neuroscience to Treatment (CRC Press, 2006). In his study, titled, “The Costs of Autism,” Ganz says that autism costs $35 billion per year for the US economy.

Ganz’s analysis of the costs includes direct and indirect medical costs associated with the disorder. But he believes the $35 billion annual societal cost for caring for and treating people with autism likely underestimates the true costs because there are a number of other services that are used to support individuals with autism, such as alternative therapies and other family out-of-pocket expenses, that are difficult to measure. In addition, Ganz believes that the level of cost could be higher if there were more useful and widespread treatment options available. “Given that the federal autism research budget has been historically less than $100 million per year and given that research budgets for other conditions with similar numbers of affected individuals are sometimes orders of magnitude higher, I hope that my research can help focus more attention on directing more resources toward finding prevention and treatment options for autism,” Ganz said. (For comparison purposes, he notes estimated annual costs of other conditions, including Alzheimer’s disease ($91 billion); mental retardation ($51 billion); anxiety ($47 billion); and schizophrenia ($33 billion).

Autism is a pervasive developmental disorder (PDD) that involves severe deficits in a person’s ability to communicate and interact with others. Children with autism often have trouble using their imagination, have a limited range of interests, and may show repetitive patterns of behavior or body movements
'"/>




Page: 1 2

Related medicine news :

1. Drug Prices in India to be Monitored - NPPA to Tie up with ORG
2. Price Of Alcohol Does Not Influence Consumption
3. Delhi Sees Sharp Decline In Chicken Prices
4. Prices of eggs, egging its way upwards
5. Chicken Prices Show an Upward Trend – Consumers, Not Scared Chicken Anymor
6. The Price Paid for New Lifestyle
7. Drug Prices Hit The Roof In Malaysia
8. Expanding Price Control Detrimental for Pharma Companies: CII
9. IVF Price To Be Reduced If Women Opt For Egg Sharing Scheme
10. Fuel Price Hike Triggers Violent Protests In Nepal
11. Drug Prices Rising Faster Than Inflation
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: The Price Autism

(Date:10/6/2008)... Millions of women suffer with symptoms of men...conomic rescue plan. But the effects of our curren...aking it increasingly difficult for U.S. women to ...kstead announces new cost effective drug-free guid...a prescription. , Las Veg...
(Date:10/6/2008)..., Oct. 6 /PRNewswire-FirstCall/ -- SAP AG (NYSE: ...ed SAP as senior vice president,of the Healthcare ...e,August 1, 2008, Mr. Papandrea will help drive SA...egic software solutions to healthcare,organization...onjunction,with the 3rd annual Ambassadors Dinner ...
(Date:10/5/2008)...e blood test may help detect serious bacterial inf...lood stream infections in young infants who come t...ave no clear cause. Researchers at Children,s Hosp...eorge Washington University, show that a new diagn...y infants at high risk for SBIs while potentially ...
(Date:10/5/2008)...ittle exercise goes a long way toward helping seve...fe and complete important daily tasks, according t... , In a pre-program assessment where patients re...e per week, individuals who were more active repor...rted improvements in their ability to perform dail...
Breaking Medicine News(10 mins):Health News:Menopause Relief: Award-Winning Physician Announces New Cost Effective Drug-Free Guidelines 2Health News:Menopause Relief: Award-Winning Physician Announces New Cost Effective Drug-Free Guidelines 3Health News:SAP Appoints John Papandrea to Lead Healthcare Business Unit 2Health News:SAP Appoints John Papandrea to Lead Healthcare Business Unit 3Health News:New test could help catch serious infections in babies 2Health News:A little exercise goes a long way for severely obese 2
...lds of academia, research, government and industry...of-the-art// communications technology can make he...an emerging field that encompasses a range of heal...ectronic medical records, telemedicine, citizen-or...
...the National Rural Health Mission (NHRM) of India ...ogrammes.// The funds will be allocated through U...pecific activities. The governments of India and ...i-partner initiative Tuesday here for achieving th...
...and those affected by HIV/AIDS, a Community Based ...ai Vizhuthugal' (Tamil Nadu AIDS Initiative Roots)...m Coimbatore, Madurai, Vellore, Salem and Chennai,...g the community to undertake and develop skills fo...
...al to expand price control from 74 to 354 drugs in...dustry chamber CII today said the step will prove ...as the economy. "Healthy competition between phar...le pricing. Instead of affecting the growth by ove...
Other Medicine News:Health News:Delhi to Host E-health Global Meet Next Month 2Health News:Norway Grants $80 mn to India's Health Mission 2
(Date:10/3/2008)... REYKJAVIK, Iceland, Oct. 3 /PRNewswire-FirstCall/...ed the filing of an investigational new drug,(IND)...molecule modulator,of phosphodiesterase 4 (PDE4), ...e compound is being developed as a new and potenti...y loss and cognitive deficits associated,with Alzh...
(Date:10/2/2008)...The Study Will Compare the Results of Rosetta Geno...hich Differentiates Squamous From non Squamous ...tic Methods, A Test Based on the miRview(TM) Techn...olumbia University,s High Complexity Molecular Pat...Year, Rosetta Genomics is Expecting to Launch miR...
(Date:10/2/2008)... GOTEBORG, Sweden, October 2 /- Calab... dose study in xerostomia ("dry mouth"),patients h...studied in 45,dry mouth patients between the ages ...ct a dose for evaluation in a succeeding Phase III... the cholinesterase inhibitor,physostigmine. It is...
(Date:10/2/2008)... Data Indicate Dual Modes of Action and Synergy ...stCall/ -- Access Pharmaceuticals, Inc.,(OTC Bulle...clinical,studies on Angiolix showing that by block...nic effect as well as a direct anti-proliferative ... of human breast cancer (MX-1),Angiolix had a sig...
Breaking Medicine Technology:deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 2deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 3deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 4deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 5Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 2Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 3Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 4Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 5Xalieve(TM) Gains Momentum as Calabar AB Launches a Phase II Repeated Dose Study in Dry Mouth Patients 2Access Pharmaceuticals Presents New Data on the Company's Angiolix(R) Therapeutic Monoclonal Antibody 2Access Pharmaceuticals Presents New Data on the Company's Angiolix(R) Therapeutic Monoclonal Antibody 3Pancreatic Cancer Biomarkers Found 21825 1Pancreatic Cancer Biomarkers Found 21825 2Specific location of the TRAF1 C5 gene associated with multiple autoimmune diseases 21822 1Specific location of the TRAF1 C5 gene associated with multiple autoimmune diseases 21822 230 percent RA patients refractory to anti TNFs achieve disease remission with tocilizumab plus metho 21819 130 percent RA patients refractory to anti TNFs achieve disease remission with tocilizumab plus metho 21819 2Disc Motion Technologies Announces First Human Implants of True TSMS 28TM 29 Device 2425 1Disc Motion Technologies Announces First Human Implants of True TSMS 28TM 29 Device 2425 2
...HMOND, Va.--(BUSINESS WIRE)--May 3, 2007 - Insmed ...s from a Phase II,investigator-sponsored study of ...otonic muscular dystrophy (DM1)., Preliminary resu...University of Rochester School of Medicine and Den...oses of IPLEX up to 1,mg/kg/day in six patients me...
...ding Symbol: QPT: TSX Venture Exchange, EDMONTON, ...Tech,Inc. ("Quest" or the "Company") Quest is plea...opment of SL052 for the treatment,of prostate canc...of cancer death in,American men with approximately...rent therapeutic modalities for localized prostate...
Other Medicine Technology:Insmed Announces Promising Results From IPLEX Phase II Myotonic,Muscular Dystrophy Clinical Study 2Insmed Announces Promising Results From IPLEX Phase II Myotonic,Muscular Dystrophy Clinical Study 3Insmed Announces Promising Results From IPLEX Phase II Myotonic,Muscular Dystrophy Clinical Study 4Quest PharmaTech's Prostate Cancer Program Update 2Quest PharmaTech's Prostate Cancer Program Update 3
Bacon Bone Rongeur
Schell Rongeur
Zaufal-Jansen Ronguer
Ruskin Mini-Bone Rongeur
Medicine Products: